Moderna sheds $24 billion as cancer vaccine data is sold
A 42% cut in melanoma death or recurrence drew a sell-the-news reaction, not a rally.
What's happening
Moderna and Merck reported that their mRNA cancer vaccine cut death and recurrence by 42% in a melanoma trial. Reuters says Moderna shed about $24 billion as the data triggered a 'sell-the-news' retreat. A Handelsblatt post cites a drop of up to 26% after a data leak, and r/wallstreetbets has a thread saying the stock crashed 20% on reportedly leaked data. Merck and Moderna are already engaging with regulators.
The numbers
MRNA trades at $202.63, down 17.57%, with 19 mentions in 24 hours. Velocity is 2.7 across 4 sources, with 11 recent mentions. Press reports put the drop between 20% and 26% at its worst, so it has recovered a little since.
Our read
Chatter is high and the price is falling, so the attention isn't turning into buying. The science is the good news and the stock is the bad news. Whether the leak or a sell-the-news reaction drove it isn't settled in the evidence. Watch for regulatory filings and whether the stock holds the post-drop level.
Sources we checked
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% — Ars Technica
- Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat — Reuters
- The results are a significant advance in melanoma treatment; Merck and Moderna are already engaging with regulatory authorities to get the vaccine approved. Mor — @nwchapman@sfba.social
- 🦖 Dino Crisis si reinventa in chiave moderna, ma non ufficialmente. Il fascino del survival horror tra dinosauri e nostalgia è ancora vivo. #DinoCrisis🔗 https:/ — @spaziogames@mastodon.social
- Moderna and Merck cancer vaccine met key endpoints in melanoma trial — Hacker News
- Pharma: Kursrutsch nach Daten-Leak: Moderna bis zu 26 Prozent im Minushttps://www.handelsblatt.com/unternehmen/industrie/pharma-kursrutsch-nach-daten-leak-moder — @Handelsblatt@flipboard.com
- Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data — r/wallstreetbets
See today's live board
This story is frozen as published on October 24, 2026. The live board shows what is moving right now, scored against real money.
Open this story live → See today's live boardEarlier on Moderna
- Moderna Leak Chatter Is Loud, but Price Shows Only a 1.5% Gain October 23, 2026
- Moderna drops as much as 26% on reported cancer vaccine data leak October 23, 2026
- Moderna's cancer vaccine data just doubled the stock October 6, 2026
- Moderna's Melanoma Vaccine Trial Ignites Chatter August 19, 2026
More Stocks stories
- Coinbase draws heavy news flow, but the stock slips 2.74% October 25, 2026
- Nasdaq jumps 7.47% as an XRP treasury heads to listing October 24, 2026
- Merck shares the cancer vaccine news, with no price read October 24, 2026
- US-China Biotech Investment Curbs Dominate the Sector Conversation October 24, 2026
- SK Hynix Shelves Solidigm US IPO as Shareholder Concerns Mount October 24, 2026
- Micron up 3.15% as its CEO warns memory supply tightens through 2028 October 23, 2026
Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything — you decide.